Want to see IN:SRPL full AI Analyst Report?
Shree Ram Proteins Ltd. (SRPL) AI Stock Analysis
Shree Ram Proteins Ltd.
(NSE:SRPL)
The overall stock score of 38 reflects extreme financial and operational distress. The most significant factor is the complete cessation of revenue generation, which has caused massive equity erosion and unsustainable debt levels. Firmly bearish technical trends and distressed valuation metrics further compound the severe downside risk, making the stock highly speculative.
Shree Ram Proteins Ltd. (SRPL) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 145.66M
- Dividend Yield
- ―
- Average Volume (3M)
- 253.74K
- Price to Earnings (P/E)
- -0.5
- Beta (1Y)
- 0.45
- Revenue Growth
- ―
- EPS Growth
- 43.06%
- Country
- India
- Employees
- 24
- Sector
- General
- Sector Strength
- 55
- Industry
- Agricultural Farm Products
Shree Ram Proteins Ltd. Business Overview & Revenue Model
Company Description
Shree Ram Proteins Limited, an Indian company, specializes in the processing of cotton seeds. Its product portfolio is extensive, featuring various cotton seed derivatives like linter, meal, hull, and both wash and refined oils. Beyond cotton, the co...
How the Company Makes Money
SRPL generates revenue primarily through the sale of agricultural commodity products and related processed outputs (i.e., revenue recognized when commodities/finished goods are delivered/sold to customers). Key revenue streams typically include (a) t...
Shree Ram Proteins Ltd. Financial Statement Overview
Summary
The company is experiencing severe financial distress, highlighted by zero revenue over the past two years, massive net losses, and dangerously high leverage with a debt-to-equity ratio of 2.42. The deeply negative return on equity and structurally unsustainable cash flows pose critical existential threats.
Income Statement
5Very NegativeBalance Sheet
15Very NegativeCash Flow
25Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.00K | 0 | 0 | 147.66M | 1.63B | 2.88B |
| Gross Profit | -60.85M | -61.39M | -195.24M | -45.57M | 145.69M | 174.93M |
| EBITDA | -79.56M | -91.70M | -169.38M | -78.65M | 105.07M | 136.20M |
| Net Income | -146.53M | -101.08M | -210.75M | -95.85M | 38.45M | 61.41M |
Balance Sheet | ||||||
| Total Assets | 0 | 694.70M | 787.27M | 982.56M | 1.06B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 135.00K | 135.00K | 136.00K | 970.00K | 425.00K | 313.31M |
| Total Debt | 0 | 371.45M | 381.37M | 369.40M | 369.48M | 425.14M |
| Total Liabilities | -153.42M | 541.28M | 532.49M | 517.65M | 500.07M | 638.17M |
| Stockholders Equity | 153.42M | 153.42M | 254.79M | 464.91M | 560.73M | 522.31M |
Cash Flow | ||||||
| Free Cash Flow | 0 | 9.73M | -12.81M | 5.83M | -214.48M | 360.12M |
| Operating Cash Flow | 0 | 9.73M | -12.81M | 5.86M | -202.00M | 362.66M |
| Investing Cash Flow | 0 | 283.00K | 0 | 9.04M | -12.39M | -2.44M |
| Financing Cash Flow | 0 | -10.02M | 11.97M | -14.35M | -98.50M | -56.87M |
Shree Ram Proteins Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SRPL, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.34, and below the 200-day MA of 0.42, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SRPL.
Shree Ram Proteins Ltd. Peers Comparison
Overall Rating
IN:GODREJAGRO72Outperform
IN:DBOL64Neutral
IN:MGEL59Neutral
IN:VENKEYS53Neutral
IN:SANWARIA43Neutral
IN:SRPL38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | INR 106.57B | 23.82 | ― | 1.99% | 8.58% | -1.86% | |
| 64Neutral | INR 7.79B | 9.21 | ― | 1.27% | 10.24% | ― | |
| 59Neutral | INR 5.74B | 14.41 | ― | 0.06% | 44.23% | 8.18% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 21.12B | 12.22 | ― | 0.67% | 18.28% | 202.79% | |
| 43Neutral | INR 360.69M | -3.70 | ― | ― | 296.49% | 19.23% | |
| 38Underperform | INR 145.66M | -0.50 | ― | ― | ― | 43.06% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:SRPL | Shree Ram Proteins Ltd. | 0.34 | -0.38 | -52.78% | |
| IN:DBOL | Dhampur Bio Organics Ltd | 117.35 | 38.45 | 48.73% | |
| IN:GODREJAGRO | Godrej Agrovet Limited | 553.85 | -94.65 | -14.59% | |
| IN:MGEL | Mangalam Global Enterprise Ltd. | 17.41 | 3.31 | 23.47% | |
| IN:SANWARIA | Sanwaria Consumer Ltd | 0.49 | 0.00 | 0.00% | |
| IN:VENKEYS | Venky's (India) Limited | 1499.25 | -24.66 | -1.62% |
Shree Ram Proteins Ltd. Corporate Events
Shree Ram Proteins Shareholders Approve Related-Party Sale of Undertaking via E-Voting
Shree Ram Proteins Ltd. conducted an Extraordinary General Meeting (EOGM) on March 5, 2026, via video conferencing, where shareholders participated through remote and live e-voting facilitated by NSDL in compliance with Ministry of Corporate Affairs...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 24, 2026